Therapy effects of testosterone on the recovery of bone defects;Therapieeffekte von testosteron auf die heilung von knochendefekten

Zeitschrift fur Orthopadie und Unfallchirurgie

Volumn 146, Issue 1, 2008, Pages 59-63

  Maus, Uwe ^a   Andereya, S ^a   Schmidt, H ^a   Zombory, G ^b   Gravius, S ^c   Ohnsorge, J A K ^a   Niedhart, C ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b St Elisabeth Krankenhaus   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Androgen; Bone defect; DHT; Osteoblast; Osteogenesis

Indexed keywords

5BETA ANDROSTANOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; CONTROLLED STUDY; DIAPHYSIS; FEMUR; HISTOLOGY; MORPHOMETRICS; NONHUMAN; RAT; TRABECULAR BONE;

EID: 40849086530     PISSN: 1864-669     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-989436     Document Type: Article

References (36)

1. Strates BS, Stock AJ, Connolly JF. Skeletal repair in the aged: a preliminary study in rabbits. Am J Med Sci 1988; 296: 266-269
2. Quarto R, Thomas D, Liang CT. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calc Tissue Int 1995; 56: 123-129
3. Niedhart C, Pingsmann A, Jürgens C, Marr A, Blatt R, Niethard FU. Komplikationen nach Entnahme autologen Knochens aus dem ventralen und dorsalen Beckenkamm - eine prospektive, kontrollierte Studie. Z Orthop 2003; 141: 481-486
4. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989; 3: 192-195
5. Deijkers RL, Bloem RM, Petit PL, Brand R, Vehmeyer SB, Veen MR. Contamination of bone allografts: analysis of incidence and predisposing factors. J Bone Joint Surg [Br] 1997; 79: 161-166
6. Tomford WW, Starkweather RJ, Goldman MH. A study of the clinical incidence of infection in the use of banked allograft bone. J Bone Joint Surg [Am] 1981; 63: 244-248
7. Lu J, Descamps M, Dejou J, Koubi G, Hardouin P, Lemaitre J, Proust JP. The biodegradation mechanism of calcium phosphate biomaterials in bone. J Biomed Mater Res 2002; 63: 408-412
8. Wang JS, Aspenberg P. Basic fibroblast growth factor promotes bone ingrowth in porous hydroxyapatite. Clin Orthop Relat Res 1996; 333: 252-260
9. Hollinger JO, Leong K. Poly (-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials 1996; 17: 187-194
10. Koempel JA, Patt BS, O'Grady K, Wozney J, Toriumi DM. The effect of recombinant human bone morphogenetic protein-2 on the integration of porous hydroxyapatite implants with bone. J Biomed Mater Res 1998; 41: 359-363
11. Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg [Am] 2001; 83: 803-816
12. Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT, Baylink D. Androgens directly stimulate proliferation on bone cells in vitro. Endocrinology 1989; 124: 1576-1579
13. Weisman Y, Cassorla F, Malozowski S, Krieg RJ, Goldray D, Kaye AM, Sömjen D. Sex-specific response of bone cells to gonadal steroids: modulation in perinatally androgenized females and in testicular feminized rats. Steroids 1993; 58: 126-133
14. Vanderschueren D, Van Herck E, Suiker AM, Visser WJ, Schot LP, Bouillon R. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology 1992; 135: 2906-2916
15. Vanderschueren D, Van Herck E, Suiker AMH, Visser WJ, Geussens P, Schot LPC, Bouillon R, Rush EB, Einhorn TA. Bone and mineral metabolism in the androgen resistant (testicular feminized) male rat. J Bone Miner Res 1993; 8: 799-807
16. Niedhart C, Koch S, Maus U, Redmann E, Siebert C, Niedhart FU. A composite of injectable tricalcium phosphate and modified rhBMP-2 is superior to autologous bone graft in rats. J Biomed Mater Res 2003; 65A:17-23
17. Niedhart C, Maus U, Redmann E, Siebert CH, Niethard FU. In vivo testing of a new in situ setting β-tricalcium phosphate cement for osseous reconstruction. J Biomed Mater Res 2001; 55: 530-537
18. Feighan JE, Davy D, Prewet AB, Stevenson S. Induction of bone by a demineralized bone matrix gel: a study in a rat femoral defect model. J Orthop Res 1995; 13: 881-891
19. Hass HJ, Krause H, Kroker S, Wagemann W, Meyer F. Bone formation using human demineralised bone matrix (Grafton) for the treatment of bone cysts in children. Eur J Pediatr Surg 2007; 17: 45-49
20. An HS, Simpson JM, Glover JM, Stephany J. Comparison between allograft plus demineralized bone matrix versus autograft in anterior cervical fusion. A prospective multicenter study. Spine 1995; 20: 2211-2216
21. Martin Jr GJ, Boden SD, Titus L, Scarborough NL. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis. Spine 1999; 24: 637-645
22. Cammisa Jr FP, Lowery G, Garfin SR, Geisler FH, Klara PM, McGuire RA, Sassard WR, Stubs H, Block JE. Two-year fusion rate equivalency between Grafton DBM gel and autograft in posterolateral spine fusion: a prospective controlled trial employing a side-by-side comparison in the same patient. Spine 2004: 29: 660-666
23. Maus U, Andereya S, Gravius S, Ohnsorge JAK, Siebert CH, Niedhart C. BMP-2 incorporated in a tricalcium phosphate bone substitute enhances bone remodelling in sheep. J Biomat Appl 2008; im Druck
24. Kasperk CH, Fitzsimmons R, Strong D, Wergedal J, Mohan S, Jennings J, Baylink DJ. Studies on the mechanisms whereby androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab 1990; 71: 1322-1329
25. Gruber HE, Ivey JL, Thompson ER, Chesnut CH, Baylink DJ. Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis. Mineral Electrolyte Metab 1986; 12: 246-254
26. Frankle M, Borrelli J. The effects of testosterone propionate and methenolone enanthate on the healing of humeral osteotomies in the Wistar rat. J Invest Surg 1990; 3: 93-113
27. Tarsoly E, Janossy J, Kosztura L. Effect of testosterone on fracture healing in hypophysectomised rats. Acta Histochem 1979; 65: 25-33
28. Lu TW, O'Connor JJ, Taylor SJG, Walker PS. Influence of muscle activity of the forces of the femur: comparison between in vivo measurements and calculation. Trans Orthop Res Soc 1997; 22: 721
29. Burr DB. Muscle strength, bone mass and age-related bone loss. J Bone Miner Res 1997; 12: 1547-1551
30. El Haj AJ, Minter SL, Rawlinson SCF, Suswillo R, Lanyon LE. Cellular responses to mechanical loading in vitro. J Bone Miner Res 1990; 5: 923-932
31. Chow JWM, Fox SW, Lean JM, Chambers TJ. Role of nitric oxide and prostaglandins in mechanically induced bone formation. J Bone Miner Res 1998; 13: 1039-1044
32. Fujimura R, Ashizawa N, Watanabe M, Mukai N, Amagai H, Fukubayashi T, Hayashi K, Tokuyama K, Suzuki M. Effect of resistance exercise training on bone formation and resorption in young male subjects assessed by biomarker of bone metabolism. J Bone Miner Res 1997; 12: 656-662
33. Wang C, Eyre DE, Clark R, Kleinberg D, Neman C, Iranmanesh A, Veldhuis J, Dudley RE, Berman N, Davidson T, Barstow TJ, Sinow R, Alexander G, Swerdloff RS. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men - a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3654-3662
34. Baran DT, Bergfeld MA, Teitelbaum SL, Avioli LV. Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcif Tiss Res 1978; 26: 103-106
35. Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukri K, Smith J. Comparison of the effects of estrogen alone and estrogen plus androgen on biomechanical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 1996; 81: 37-43
36. Abraham D, Carpenter PC. Issues concerning androgen replacement therapy in postmenopausal women. Mayo Clin Proc 1997; 72: 1051-1055